GlaxoSmithKline: PharmaVitae Profile 2005

The original one-stop information shop

UK head office: +44 (0) 1494 771930 International answering service: US +1 (508) 861 0401 email:

Industry

Other Reports

GlaxoSmithKline: PharmaVitae Profile 2005

Report

GlaxoSmithKline: PharmaVitae Profile 2005 is a marketing resource from Datamonitor, a leading provider of online data, analytic and forecasting platforms for key vertical sectors. It helps 5,000 of the world's largest companies profit from better, more timely decisions.

From:

$5700

Overview |

Table of contents |

More publications

Introduction

This analysis examines the current position and future outlook for GSK in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Scope

Highlights

Reasons to Purchase

Benchmark GSK's performance against key rivals in the ethical pharmaceutical sector
Learn how GSK will deploy lifecycle management and in-licensing strategies in order to maximize revenues from its mature marketed portfolio
Understand the challenges of GSK's weak late-stage pipeline, and how these must be met if the promising early pipeline is to have time to deliver

Report Details:

Publisher:

Datamonitor

Type:

Market Study - October 2005

First Publication Date:

17/10/2005